Literature DB >> 22790258

Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.

Claudia Rizzo1, Sergio Rizzo, Elisabetta Scirè, Danilo Di Bona, Carlo Ingrassia, Giovanni Franco, Roberto Bono, Gerlando Quintini, Calogero Caruso.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22790258      PMCID： PMC3496241          DOI： 10.2450/2012.0122-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  49 in total

1.  Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.

Authors:  Sarah L Allford; Beverley J Hunt; Peter Rose; Samuel J Machin
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

2.  Thrombotic thrombocytopenic purpura in systemic sclerosis.

Authors:  J C Barton; D A Saway; W D Blackburn; S Fallahi; J T Jakes; G S Alarcón
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

3.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

4.  Thrombotic thrombocytopenia purpura in a patient with systemic sclerosis.

Authors:  J Yusin; K Lewin; P Clements
Journal:  J Clin Rheumatol       Date:  2001-04       Impact factor: 3.517

5.  Renal failure due to scleroderma with thrombotic microangiopathy developing in a woman treated with carboplatin for ovarian cancer.

Authors:  M Karim; E Vaux; D R Davies; P D Mason
Journal:  Clin Nephrol       Date:  2002-11       Impact factor: 0.975

6.  Thrombotic thrombocytopenic purpura as an initial presentation of limited systemic sclerosis.

Authors:  T E Towheed; T P Anastassiades; S E Ford; P M Ford; P Lee
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

7.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?

Authors:  Christine M Cserti; Stephen Landaw; Lynne Uhl
Journal:  J Clin Apher       Date:  2007-02       Impact factor: 2.821

9.  Fulminant thrombotic thrombocytopenic purpura in a patient with the limited form of scleroderma: successful outcome using plasma exchange.

Authors:  S Cookson; M L Krueger; R M Bennett
Journal:  J Rheumatol       Date:  1991-06       Impact factor: 4.666

10.  Pregnancy-associated thrombotic thrombocytopenic purpura.

Authors:  Jens Gerth; Ekkehard Schleussner; Karim Kentouche; Martin Busch; Mandy Seifert; Gunter Wolf
Journal:  Thromb Haemost       Date:  2009-02       Impact factor: 5.249
View more
  7 in total

Review 1.  Haemostasis and immunity: cross-talking systems?

Authors:  Wilma Barcellini
Journal:  Blood Transfus       Date:  2013-05-17       Impact factor: 3.443

2.  Does corticosteroid treatment cause prolonged recovery and increased total bilirubin level in severe ADAMTS-13-deficient TTP patient?

Authors:  Zeynel Abidin Sayiner; Didar Yanardag Acik; Mehmet Yilmaz; Salih Subari; Ayse Ozlem Mete; M Sinan Dai
Journal:  Wien Klin Wochenschr       Date:  2015-01-10       Impact factor: 1.704

3.  Changes in plasma von Willebrand factor and von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura: A case report.

Authors:  Yu Gao; Liping Wang; Guangxian Nan
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

4.  Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report.

Authors:  Jian Chen; Jing-Xia Jin; Xiao-Fei Xu; Xuan-Xuan Zhang; Xing-Nong Ye; Jian Huang
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

Review 5.  Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.

Authors:  Tugrul Elverdi; Ahmet Emre Eskazan
Journal:  Drug Des Devel Ther       Date:  2019-04-17       Impact factor: 4.162

Review 6.  The Challenges in Diagnosis and Management of Acquired Thrombotic Thrombocytopenic Purpura: Consensus Report from Three Gulf Countries.

Authors:  Murtadha Al-Khabori; Faisal Alsayegh; Hasan Al Yaseen; Sabir Hussien; Amar Lal; Muna Al Rasheed; Mohammad Al Bader; Salam Al Kindi; Mahmoud Marashi
Journal:  Oman Med J       Date:  2022-07-31

Review 7.  Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology.

Authors:  Sergey Okhota; Ivan Melnikov; Yuliya Avtaeva; Sergey Kozlov; Zufar Gabbasov
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.